Find public sector tenders
Search and find UK govt public sector tenders - full contract/frameworks/DPS/Prior information notice
Search for tenders by ...
Provision of Oncotype DX Breast Recurrence Score Assay
Buyer : Belfast Health and Social Care Trust
Wales
N/A
Provision of Oncotype DX Breast Recurrence Score Assay.
Buyer : UK Research & Innovation
London
N/A
EARLY METRICS INDEX SCORE
Subscription to S&P Scorecards to support Credit risk assessments for UKEF.
Buyer : UK EXPORT FINANCE
Subscription to S&P Scorecards to support Credit risk assessments for UKEF.
SUPPLY OF ONCOTYPE DX BREAST RECURRENCE SCORE TEST
Buyer : hull royal infirmary
Yorkshire and The Humber
N/A
This notice is being posted to inform of an award of contract to Exact Sciences UK Ltd for the supply of Oncotype DX Breast Recurrence Score Tests . The award is made via the NHS Supply Chain Framework Agreement 2023/s 000-028831.
Exact Sciences - Oncotype DX Breast Recurrence Score tests
Buyer : norfolk and norwich university hospitals nhs foundation trust
Call off contract from framework.
Oncotype DX Breast Recurrence Score test
Buyer : norfolk and norwich university hospitals nhs foundation trust
East of England
N/A
System for prognosis of breast cancer recurrence
Buyer : Accent Housing Ltd
Wales
N/A
The scope is to cover the full suite of design, construction and associated related services and supply to deliver an exciting and functional office space for Accent employees and key stakeholders to work from in Bradford. Accent is aware of the many ....
Buyer : accent housing ltd
N/A
N/A
The scope is to cover the full suite of design, construction and associated related services and supply to deliver an exciting and functional office space for Accent employees and key stakeholders to work from in Bradford. Accent is aware of the many ....
Contract finder notice for the purchase of Security Scorecard Platform, awarded to Security Scorecard Inc.
Rail Scorecard Evaluators
Signup now for more tenders
Unlock the details of all tenders
Get to know more about our latest features.
